2022 - Research.com Microbiology in South Africa Leader Award
Robin M. Warren mostly deals with Mycobacterium tuberculosis, Tuberculosis, Drug resistance, Genetics and Genotype. His studies in Mycobacterium tuberculosis integrate themes in fields like Virology, Microbiology, Internal medicine, Phylogenetics and Restriction fragment length polymorphism. His Virology research incorporates themes from Antibacterial agent, Ethambutol, DNA profiling, Sputum and Polymerase chain reaction.
His Tuberculosis research is multidisciplinary, incorporating perspectives in Incidence, Disease, Immunology and Epidemiology. His research integrates issues of Mutation, Antibiotic resistance, Rifampicin and Intensive care medicine in his study of Drug resistance. His studies deal with areas such as Mycobacterium tuberculosis complex, DNA sequencing and Gene mutation as well as Genotype.
Robin M. Warren spends much of his time researching Tuberculosis, Mycobacterium tuberculosis, Virology, Drug resistance and Genotype. Robin M. Warren interconnects Internal medicine, Molecular epidemiology and Immunology in the investigation of issues within Tuberculosis. His Mycobacterium tuberculosis study combines topics in areas such as Genetics, Genome, DNA profiling, Microbiology and Restriction fragment length polymorphism.
Robin M. Warren has researched Virology in several fields, including Mycobacterium tuberculosis complex, Mycobacterium bovis, rpoB and Polymerase chain reaction. His Drug resistance research is multidisciplinary, incorporating elements of Pyrazinamide, Ethambutol and Isoniazid. The concepts of his Genotype study are interwoven with issues in Veterinary medicine and Typing.
His main research concerns Tuberculosis, Mycobacterium tuberculosis, Virology, Drug resistance and Mycobacterium bovis. His Tuberculosis research includes themes of Internal medicine, Disease and Immunology. The various areas that Robin M. Warren examines in his Mycobacterium tuberculosis study include Genetics, Genome, Whole genome sequencing and Genotype.
His work deals with themes such as Mycobacterium tuberculosis complex, Concordance, Molecular epidemiology, Sanger sequencing and rpoB, which intersect with Virology. His Drug resistance study combines topics from a wide range of disciplines, such as Bedaquiline, Regimen and Genetic diversity. The study incorporates disciplines such as Ceratotherium simum, Rhinoceros and Interferon gamma, Immune system in addition to Mycobacterium bovis.
Robin M. Warren mainly focuses on Tuberculosis, Mycobacterium tuberculosis, Drug resistance, Internal medicine and Immunology. His Tuberculosis research includes elements of Multiple drug resistance, Disease and Intensive care medicine. In his study, which falls under the umbrella issue of Multiple drug resistance, Virology is strongly linked to Mycobacterium tuberculosis complex.
Robin M. Warren performs integrative study on Mycobacterium tuberculosis and Extramural in his works. His work carried out in the field of Drug resistance brings together such families of science as Phenotype, Microevolution and Genetic diversity. His Immunology research is multidisciplinary, relying on both RNA and Pulmonary tuberculosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology
Karine Brudey;Jeffrey R Driscoll;Leen Rigouts;Wolfgang M Prodinger.
BMC Microbiology (2006)
Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative Treatment
A van Rie;R Warren;M Richardson;T C Victor.
The New England Journal of Medicine (1999)
Rate of Reinfection Tuberculosis after Successful Treatment Is Higher than Rate of New Tuberculosis
Suzanne Verver;Robin M. Warren;Nulda Beyers;Madalene Richardson.
American Journal of Respiratory and Critical Care Medicine (2005)
Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage
Matthias Merker;Camille Blin;Stefano Mona;Nicolas Duforet-Frebourg.
Nature Genetics (2015)
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley.
The Lancet Respiratory Medicine (2017)
Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions
Nicolaas C Gey van Pittius;Samantha L Sampson;Hyeyoung Lee;Yeun Kim.
BMC Evolutionary Biology (2006)
Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis
Maha R Farhat;B Jesse Shapiro;Karen J Kieser;Razvan Sultana.
Nature Genetics (2013)
Patients with active tuberculosis often have different strains in the same sputum specimen.
Robin M. Warren;Thomas C. Victor;Elizabeth M. Streicher;Madalene Richardson.
American Journal of Respiratory and Critical Care Medicine (2004)
Drug resistance in Mycobacterium tuberculosis.
Johnson R;Streicher Em;Louw Ge;Warren Rm.
Current Issues in Molecular Biology (2006)
Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting
Grant Theron;Jonny Peter;Richard van Zyl-Smit;Hridesh Mishra.
American Journal of Respiratory and Critical Care Medicine (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: